Medicine & Life Sciences
Pulmonary Arterial Hypertension
100%
Pulmonary Hypertension
69%
Systemic Scleroderma
36%
Right Ventricular Function
28%
Lung
27%
Survival
24%
Xanthine Dehydrogenase
16%
Hypoxia
15%
Right Ventricular Dysfunction
15%
Apoptosis
12%
ambrisentan
12%
Caspase 3
11%
Heart Failure
11%
Tadalafil
10%
Vascular Resistance
10%
Endostatins
10%
Pulmonary Artery
10%
Cardiac Catheterization
9%
Mortality
9%
Macrophage Migration-Inhibitory Factors
9%
Magnetic Resonance Spectroscopy
9%
Hemodynamics
9%
Endothelial Cells
9%
Okadaic Acid
8%
Exercise
8%
Familial Primary Pulmonary Hypertension
7%
Mitogen-Activated Protein Kinases
7%
Protein Kinases
7%
Tuberous Sclerosis 2
7%
Magnetic Resonance Imaging
7%
Stroke Volume
7%
Serum
6%
Smoke
6%
Tobacco Products
6%
Lung Compliance
6%
Schnitzler Syndrome
6%
Heart Ventricles
6%
Pressure
6%
Catheters
5%
Semaxinib
5%
Registries
5%
Febuxostat
5%
Pulmonary Wedge Pressure
5%
Brain Natriuretic Peptide
5%
MAP Kinase Kinase Kinase 5
5%
Vascular Endothelial Growth Factor Receptor-1
5%
Therapeutics
5%
Capillary Permeability
5%
Cyclic GMP-Dependent Protein Kinases
5%
Tuberous Sclerosis
5%